humanitarian
Archived signal
Human medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation: 01/07/2019, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
6 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation: 01/07/2019, Revision: 14, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation: 01/07/2019, Revision: 14, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: AuthorisedEMA What Is NewVeterinary medicines European public assessment report (EPAR): Eravac, rabbit haemorrhagic disease vaccine (inactivated), Status: WithdrawnEMA What Is NewVeterinary medicines European public assessment report (EPAR): Eravac, rabbit haemorrhagic disease vaccine (inactivated), Status: Withdrawn4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources